COX-2 CLASS OF DRUGS HAS MINIMAL BENEFIT OVER NSAIDS – (11-07-05)

Prescriptions for Chronic High-Dose Cyclooxygenase-2 Inhibitors are Often Inappropriate and Potentially Dangerous

How much MORE apparent does it have to be that physicians are not reading their own literature? We’ve learned that the COX-2 class of drugs is very expensive, has minimal benefit over other NSAIDs and has significant cardiovascular risk, and yet there’re STILL being used inappropriately!! Good to know that the drug reps are earning their commissions…

Read entire article here

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email: